3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Dermatologic
1
Conditions
Lymphoma, T-Cell, Peripheral
10
Recurrence
7
Lymphoma
5
Lymphoma, T-Cell
4
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large-Cell, Anaplastic
3
Hodgkin Disease
3
Waldenstrom Macroglobulinemia
2
Unspecified Adult Solid Tumor, Protocol Specific
2
Sezary Syndrome
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Lung Neoplasms
2
Immunoblastic Lymphadenopathy
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Smoking
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
85
Rituximab
80
Peripheral Blood Stem Cell Transplantation
60
fludarabine phosphate
58
Filgrastim
40
Mycophenolic Acid
37
Whole-Body Irradiation
35
Cyclosporine
35
Radiotherapy
33
Etoposide
33
Busulfan
33
Tacrolimus
31
Antilymphocyte Serum
28
Melphalan
26
Methotrexate
22
Prednisone
19
Bortezomib
19
Methylprednisolone
16
Cytarabine
16
Vincristine
15
Lenalidomide
15
Flow Cytometry
14
Cord Blood Stem Cell Transplantation
13
sargramostim
12
Doxorubicin
12
Bendamustine Hydrochloride
12
fludarabine
11
Dexamethasone
11
Carmustine
11
Carboplatin
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphoma, B-Cell, Marginal Zone
×
10-propargyl-10-deazaaminopterin
×
Clear all
NCT01947140
2022-11-23
PDX+Romi
Columbia University
Phase 1/2
Completed
57 enrolled